Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Boynton Beach, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Brandon, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Brandon, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Doral, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Doral, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Hialeah, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Jacksonville, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami Lakes, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Pembroke Pines, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Pinellas Park, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Sarasota, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
West Palm Beach, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Decatur, GA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Decatur, GA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Meridian, ID
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Meridian, ID
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Lexington, KY
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Louisville, KY
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Worcester, MA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Ann Arbor, MI
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Grand Rapids, MI
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Lansing, MI
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Lansing, MI
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Tupelo, MS
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Tupelo, MS
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Las Vegas, NV
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Freehold, NJ
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Freehold, NJ
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Durham, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Greenville, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Salisbury, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Wilmington, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Cincinnati, OH
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Columbus, OH
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Middleburg Heights, OH
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Oklahoma City, OK
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Duncansville, PA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Media, PA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Media, PA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Wyomissing, PA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Charleston, SC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Fort Mill, SC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Fort Mill, SC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Jackson, TN
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Jackson, TN
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Memphis, TN
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Amarillo, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Amarillo, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Baytown, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Baytown, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Beaumont, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Beaumont, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Corpus Christi, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Cypress, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Cypress, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
El Paso, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
El Paso, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Galveston, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Galveston, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Houston, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Mesquite, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Mesquite, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Nassau Bay, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
San Antonio, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Sugar Land, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Tomball, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Tomball, TX
Click here to add this to my saved trials